STOCK TITAN

Nurix Therapeutics officer proposes $95.5K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Gwenn M. Hansen, an officer of Nurix Therapeutics, Inc., reported a proposed sale of 4,111 common shares, with an aggregate market value of $95,457.42 and an approximate sale date of August 4, 2026. The shares are listed as restricted stock units acquired from the issuer on July 30, 2026.

The sales history lists 5,394 shares sold June 25, 2026, for gross proceeds of $107,880 under a 10b5-1 sales entry. The listed plan adoption or instruction date, if relying on Rule 10b5-1, is February 26, 2026. Nurix shares outstanding are listed as 103,781,683.

Proposed sale 4,111 common shares Approximate sale date August 4, 2026
Aggregate market value $95,457.42 Proposed sale of 4,111 common shares
Shares outstanding 103,781,683 shares Nurix shares outstanding listed in the notice
Prior sale 5,394 common shares Sold June 25, 2026
Gross proceeds $107,880 June 25, 2026 sale
Plan adoption or instruction date February 26, 2026 If relying on Rule 10b5-1
Restricted Stock Units financial
"Nature of Acquisition Transaction: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 Sales regulatory
"10b5-1 Sales for GWENN M HANSEN"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Aggregate Market Value financial
"Number of Shares or Other Units To Be Sold | Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Gross Proceeds financial
"Amount of Securities Sold | Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NRIX shares is Gwenn M. Hansen proposing to sell?

Gwenn M. Hansen reported a proposed sale of 4,111 common shares, with an aggregate market value of $95,457.42 and an approximate sale date of August 4, 2026.

How many NRIX shares did Gwenn M. Hansen recently sell?

The sales history lists 5,394 common shares sold June 25, 2026, for gross proceeds of $107,880 under the 10b5-1 sales heading.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading